期刊文献+

高糖上调大鼠主动脉平滑肌细胞骨桥蛋白表达 被引量:4

High glucose induces up-regulation of osteopontin in rat aortic vascular smooth muscle cells
下载PDF
导出
摘要 目的探讨高糖对大鼠血管平滑肌细胞(VSMCs)骨桥蛋白(OPN)表达的影响及机制。方法 SD大鼠腹腔注射链脲佐菌素复制1型糖尿病模型,免疫组化、RT-PCR和Western blot检测大鼠主动脉OPN和PCNA的表达;大鼠主动脉VSMCs经含正常糖(5.5 mmol/L)、高糖(25 mmol/L)、甘露醇(25 mmol/L)、高糖+GF109203X(蛋白激酶C抑制剂,10μmol/L)、高糖+NAC(NF-κB抑制剂,10μmol/L)的DMEM处理48 h,免疫荧光及Western blot检测OPN的表达,Western blot分析PCNA、PKC和P65的表达。结果高糖血症大鼠主动脉VSMCs高表达OPN及PCNA。原代VSMCs经高糖刺激后OPN、PCNA、PKC及P65表达明显增加;GF109203X和NAC均可下调PCNA的高表达,但仅GF109203X抑制高糖诱导的OPN高表达。结论高糖可能通过激活PKC信号诱导OPN表达并促进VSMCs增殖,从而在糖尿病性血管并发症中起作用。 Objective To investigate the effects and mechanism of high glucose on the osteopontin(OPN) expression in rat aortic vascular smooth muscle cells(VSMCs).Methods SD rats were intraperitoneally injected with streptozotocin,OPN and PCNA expression in rat thoracic aortas were detected by immunohistochemical staining,RT-PCR and Western blot analysis;After primary rat aortic VSMCs treated with DMEM medium supplemented with normal glucose(5.5 mmol/L),high glucose(25 mmol/L),mannitol(25 mmol/L),high glucose + GF109203X(PKC inhibitor,10 μmol/L) and high glucose + NAC(NF-κB inhibitor,10 μmol/L) for 48 h,OPN expression was examined by immunofluorescence and Western blot,expression of PCNA,PKC and P65 were assessed by Western blot analysis.Results OPN and PCNA expression increased in hyperglycemic rat aortic VSMCs.Expression of OPN,PCNA,PKC and P65 were significantly up-regulated in VSMCs exposed to high glucose.Expression of PCNA was attenuated by GF109203X and NAC in high glucose-treated VSMCs,while the expression of OPN was only inhibited by GF109203X.Conclusion High glucose induces OPN expression and cell proliferation in VSMCs and may be explained by activation of PKC signal,which play a critical role in diabetic vascular complications.
出处 《基础医学与临床》 CSCD 北大核心 2010年第8期852-856,共5页 Basic and Clinical Medicine
关键词 血管平滑肌细胞 高糖 骨桥蛋白 PKC NF-κB vascular smooth muscle cells high glucose osteopontin PKC NF-κB
  • 相关文献

参考文献9

  • 1Scatena M, Liaw L, Giachelli CM. Osteopontin: a multi- functional molecule regulating chronic inflammation and vascular disease [ J]. Arterioscler Thromb Vasc Biol, 2007, 27 ( 11 ) :2302 - 2309.
  • 2Chaulet H, Desgranges C, Renault MA, et al. Extracellular nucleotides induce arterial smooth muscle cell migraion via ospteopontin [J]. Circ Res, 2001,89(9) : 772-778.
  • 3Isoda K, Nishikawa K, Kamezawa Y, et al. Osteopontin plays an improtant role in the development of medial thickening and neointimal formation [J]. Circ Res, 2002, 91 (1): 77-82.
  • 4Ye Shan, Sun Yumei, Bie Aigui, et al. Influence of osteopontin short hairpin RNA on the proliferation and activity of rat vascular smooth muscle cells [ J ]. J Huazbong Univ Sci Technolog Med Sci, 2009, 29(2) :144 -149.
  • 5Takemoto M, Yokote K, Nishimura M, et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis [ J ]. Arterioscler Thromb Vasc Biol, 2000, 20 (3) : 624 - 628.
  • 6Ramana KV, Friedrich B, Srivastava S, et al. Activation of nuclear factor-kappa B by hyperglycemia in vascular smooth muscle ceils is regulated by aldose reductase [ J ]. Diabetes, 2004, 53(11):2910-2920.
  • 7庞晓,何培英,孙宁玲.CaN-NFAT信号通路参与苯肾上腺素介导的血管平滑肌细胞增殖[J].基础医学与临床,2009,29(10):1087-1091. 被引量:1
  • 8Isoda K, Kamezawa Y, Ayaori M, et al. Osteopotin transgenic mice fed a high-cholesterol diet develop early fatty streak lesion [J]. Circ Res, 2003, 107(5) : 679 -681.
  • 9Takemoto M, Yokote K, Yamazaki M, et al. Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle ceils [ J ]. Biochem Biophys Res Commun, 1999, 258 (3) :722 - 726.

二级参考文献7

  • 1Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[ J]. Physiol Rev, 2004, 84 : 767 - 801.
  • 2Doran AC, Meller N, McNamara CA. Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2008, 28: 812 -819.
  • 3Fiedler B, Lohmann SM, Smolenski A, et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes[J]. Proc Natl Acad Sci USA, 2002, 99:11363 -11368.
  • 4Shaw L, O'Neill S, Jones C J, et al. Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca^2+ profiles and Ca^2+ sensitisation of constriction of pressurised rat resistance arteries[J]. Br J Pharmacol, 2004, 141:678-688.
  • 5Chobanian AV. Can antihypertensive drugs reduce atherosclerosis and its clinical complications? [J].Am J Hypertens, 1994, 7: 119s - 125s.
  • 6Lipskaia L, Lompre AM. Alteration in temporal kinetics of Ca^2+ signaling and control of growth and proliferation [ J ]. Biol Cell, 2004, 96:55 -68.
  • 7Wada H, Hasegawa K, Morimoto T, et al. Calcineurin- GATA-6 pathway is involved in smooth muscle-specific transcription[J]. J Cell Biol, 2002, 156:983 -991.

同被引文献31

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部